Literature DB >> 21503907

Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India.

Chandana Pande1, Shiv Kumar Sarin, Sharda Patra, Kazila Bhutia, Siddhartha Kumar Mishra, Sangeeta Pahuja, Manjula Jain, Shikha Srivastava, Sadaf Bashir Dar, Shubha Sagar Trivedi, Chinmay K Mukhopadhyay, Ashish Kumar.   

Abstract

A large program was conducted by the Government of India to study the prevalence and profile of chronic hepatitis B virus (HBV) infection and its risk factors in pregnant women attending a tertiary care hospital in India. From September 2004 to December 2008 consecutive pregnant women attending the antenatal clinic were screened and those found positive for HBsAg were enrolled. Healthy non-pregnant women of child-bearing age, who presented for blood donation during the same period, served as controls. Women with symptoms of liver disease or those aware of their HBsAg status were excluded. Of the 20,104 pregnant women screened, 224 (1.1%) and of the 658 controls, 8 (1.2%) were HBsAg positive (P = ns). Previous blood transfusions and surgery were significant risk factors for infection with HBV. Of the women who were HBsAg positive, the ALT levels were normal in 54% of the women and HBV DNA levels were above 2,000  IU/ml in 71% of women. The median HBV DNA levels were higher in women who were HBeAg positive compared to the HBeAg negative group. The most common HBV genotype was D (84%) followed by A + D and A (8% each). In conclusion, the prevalence of HBsAg positivity among asymptomatic pregnant women in North India is 1.1% with 71% having high HBV DNA levels. These women may have a high risk of transmitting infection to their newborns.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503907     DOI: 10.1002/jmv.22017

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

Review 1.  Hepatology in India and INASL: A Ringside View.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 2.  Chronic hepatitis B virus infection and pregnancy.

Authors:  Manoj Kumar; Tarandeep Singh; Swati Sinha
Journal:  J Clin Exp Hepatol       Date:  2012-09-20

Review 3.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

Review 4.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 5.  Hepatitis B virus infection and pregnancy: a practical approach.

Authors:  Ashish Kumar
Journal:  Indian J Gastroenterol       Date:  2012-04-21

6.  Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B.

Authors:  Ranjit Chauhan; Shiv K Sarin; Manoj Kumar; Jayashree Bhattacharjee
Journal:  Hepatol Int       Date:  2011-12-02       Impact factor: 6.047

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

Review 8.  INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

Authors:  Anil Arora; Shivaram P Singh; Ashish Kumar; Vivek A Saraswat; Rakesh Aggarwal; Manisha Bangar; Pradip Bhaumik; Harshad Devarbhavi; Radha K Dhiman; Vinod K Dixit; Ashish Goel; Bhabadev Goswami; Dharmesh Kapoor; Kaushal Madan; Jimmy Narayan; Sandeep Nijhawan; Gaurav Pandey; Ramesh R Rai; Manoj K Sahu; Neeraj Saraf; Thrivikrama Shenoy; Varghese Thomas; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2017-12-16

9.  Is it the Right Time to Introduce the Hepatitis B Booster Vaccine in National Immunization Schedule? An Analysis from the Available Evidence.

Authors:  Sudip Bhattacharya; Özden Gökdemir; Md Abu Bashar; Arulmani Thiyagarajan; Amarjeet Singh
Journal:  Indian J Community Med       Date:  2021-03-01

10.  Together let us confront it: An outbreak investigation of hepatitis B in Pathanamthitta district, Kerala.

Authors:  Sangeetha Merrin Varghese; A L Sheeja; Abel K Samuel Johnson; Abey Sushan; C S Nandini; George M Chandy; P S Rakesh; Marina Rajan Joseph; Alice David; Geethu Mathew; Prince Alexander
Journal:  J Family Med Prim Care       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.